Cancer cells from other tissue origins displayed differential NANOG promoter methylation; for example, hypomethylation was observed in HeLa (25%), whereas hypermethylation was shown in MCF7, HCT116 and AGS (71%, 92% and 91%, respectively) (Figure 1B and 1C). This evidence concerns the gene NANOG and cancer.